Lexeo Therapeutics (LXEO) Current Leases (2022 - 2026)

Lexeo Therapeutics' Current Leases history runs 5 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• In Q1 2026, Current Leases rose 315.93% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (up 315.93% YoY), while the FY2025 annual figure was $518000.0, down 75.33% from the prior year.
• Current Leases came in at $2.2 million for Q1 2026 at Lexeo Therapeutics, up from $518000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $2.3 million in Q4 2022 to a low of $518000.0 in Q4 2025.
• A 5-year average of $1.9 million and a median of $2.1 million in 2024 frame the typical range for Current Leases.
• Across the five-year window, Current Leases tumbled 75.33% in 2025 and soared 315.93% in 2026, its largest moves.
• Lexeo Therapeutics' Current Leases stood at $2.3 million in 2022, then dropped by 8.75% to $2.1 million in 2023, then rose by 0.62% to $2.1 million in 2024, then sank by 75.33% to $518000.0 in 2025, then surged by 318.34% to $2.2 million in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $2.2 million, $518000.0, and $2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison